Stuart A. Arbuckle - Feb 10, 2023 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, COO
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Feb 10, 2023
Transactions value $
-$4,239,874
Form type
4
Date filed
2/14/2023, 03:53 PM
Previous filing
Feb 3, 2023
Next filing
Feb 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability -$992K -3.37K -3.5% $294.33 92.9K Feb 10, 2023 Direct
transaction VRTX Common Stock Tax liability -$1.79M -5.99K -6.45% $298.26 86.9K Feb 13, 2023 Direct
transaction VRTX Common Stock Sale -$72.6K -245 -0.28% $296.44 86.6K Feb 13, 2023 Direct F1, F2, F3
transaction VRTX Common Stock Sale -$605K -2.03K -2.34% $298.42 84.6K Feb 13, 2023 Direct F1, F2, F4
transaction VRTX Common Stock Sale -$532K -1.78K -2.1% $299.26 82.8K Feb 13, 2023 Direct F1, F2, F5
transaction VRTX Common Stock Sale -$251K -835 -1.01% $300.13 82K Feb 13, 2023 Direct F1, F2, F6
holding VRTX Common Stock 140 Feb 10, 2023 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.
F2 Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $296.44 (range $295.84 to $296.57).
F4 Open market sales reported on this line occurred at a weighted average price of $298.42 (range $297.85 to $298.80).
F5 Open market sales reported on this line occurred at a weighted average price of $299.26 (range $298.86 to $299.81).
F6 Open market sales reported on this line occurred at a weighted average price of $300.13 (range $299.93 to $300.53).